Immunologically mediated drug-induced acute renal failure.

Area of Science:

• Nephrology
• Immunology
• Pharmacology

Background:

• Drug-induced kidney injury is a significant clinical concern.
• Acute interstitial nephritis (AIN) represents the most frequent pattern of immunologically mediated renal damage.
• The pathophysiology of other drug-induced renal injuries, such as vasculitis and glomerulonephritis, remains poorly understood.

Purpose of the Study:

• To summarize the current understanding of drug-induced acute interstitial nephritis.
• To highlight the immunological mechanisms involved in AIN.
• To briefly address other less common forms of drug-induced renal injury.

Main Methods:

• Review of existing literature on drug-induced renal injury.
• Analysis of clinical and pathological features suggesting immune mechanisms in AIN.
• Discussion of identified antibodies and potential injury pathways.

Main Results:

• Acute interstitial nephritis (AIN) is frequently associated with drugs like penicillin derivatives, rifampicin, phenindione, and sulfonamides.
• Clinical and pathological findings often indicate immune-mediated pathogenesis in AIN.
• While IgG anti-TBM and IgE antibodies are rarely found, both antibody-mediated and cell-mediated injury mechanisms may occur concurrently in AIN.
• Drug-induced vasculitis and glomerulonephritis are rare, with limited understanding of their pathophysiology.

Conclusions:

• Acute interstitial nephritis is the predominant form of drug-induced kidney injury, driven by immune responses.
• Further research is needed to elucidate the mechanisms behind less common drug-induced renal pathologies like vasculitis and glomerulonephritis.